Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Figure 2

Prognostic value of circulating tumor cells according with different first-line treatments. Estimated progression-free survival and overall survival according to baseline circulating tumor cell (CTC) value (< 5 vs. ≥ 5) in patients receiving (a), (e) endocrine therapy, (b), (f) chemotherapy alone, (c), (g) chemotherapy + bevacizumab, and (d), (h) chemotherapy + human epidermal growth factor receptor-2 (HER-2)-targeting drugs. C.I., confidence interval.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us